This brand name is authorized in Nigeria.
The drug NEFIXIME contains one active pharmaceutical ingredient (API):
1
|
UNII
97I1C92E55 - CEFIXIME
|
|
Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-7843 | Suspension | NEFIXIME ORAL SUSPENSION SUSP 100 mg 1X60ML | 99 RNW-PP-292191 NEFIXIME ORAL SUSPENSION CEFIXIME 100MG CEFIXIME 100MG (EXCIPIENTS: Sucrose, Sodium Benzoate, Sunset yellow supra colour, Orange flavour, Colloidal silicone dioxide, Aspartame, Xanthan gum) A4-7843 Drugs Imported Products 1X60ML POM 1 11/22/2022 NECTAR HEALTHCARE LIMITED, RESIDENCE ROAD, GBAGADA PHASE 2 LAGOS LAGOS 14141978 kingsley.okeke2@gmail.com CHIROS PHARMA, VILLAGE. - LOHARON, P.O-GHATTI, TEASIL & DISTT,SOLAN (H.P) INDIA. , India | 21/12/2023 |
| B4-7838 | Tablet | NEFIXIME 400 TABLET TAB 400 mg 1 X 10 | 100 RNW-PP-292195 NEFIXIME 400 TABLET CEFIXIME 400MG CEFIXIME 400MG, (EXCIPIENTS: HPMC E 15 USP, M.C.C.P (102) USP, SODIUM STARCH GLYCOLLATE USP, TALC USP, CALCIUM STEARATE USP, COLLOIDAL SILICON DIOXIDE USP) B4-7838 Drugs Imported Products 1X10TABLET POM 1 11/24/2022 NECTAR HEALTHCARE LIMITED, RESIDENCE ROAD, GBAGADA PHASE 2 LAGOS LAGOS 14141978 kingsley.okeke2@gmail.com CHIROS PHARMA, VILLAGE. - LOHARON, P.O-GHATTI, TEASIL & DISTT,SOLAN (H.P) INDIA. , India | 21/12/2023 |
| B4-7947 | Tablet | Nefixime 200 Tablet TAB 200 mg | 21/12/2020 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DD08 | Cefixime | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-7843, B4-7838, B4-7947 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.